Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Total Non-Current Liabilities (2016 - 2025)

Mesa Laboratories (MLAB) has disclosed Total Non-Current Liabilities for 14 consecutive years, with $237.2 million as the latest value for Q4 2025.

  • Quarterly Total Non-Current Liabilities fell 9.14% to $237.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $237.2 million through Dec 2025, down 9.14% year-over-year, with the annual reading at $261.0 million for FY2025, 8.66% down from the prior year.
  • Total Non-Current Liabilities hit $237.2 million in Q4 2025 for Mesa Laboratories, down from $240.1 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $321.5 million in Q4 2023 to a low of $194.5 million in Q1 2021.
  • Historically, Total Non-Current Liabilities has averaged $262.6 million across 5 years, with a median of $261.6 million in 2023.
  • Biggest five-year swings in Total Non-Current Liabilities: soared 57.12% in 2022 and later decreased 18.8% in 2024.
  • Year by year, Total Non-Current Liabilities stood at $317.0 million in 2021, then dropped by 15.59% to $267.6 million in 2022, then increased by 20.13% to $321.5 million in 2023, then dropped by 18.8% to $261.0 million in 2024, then decreased by 9.14% to $237.2 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for MLAB at $237.2 million in Q4 2025, $240.1 million in Q3 2025, and $250.6 million in Q2 2025.